Induction of the p53 Tumor Suppressor in Cancer Cells through Inhibition of Cap-Dependent Translation

REFERENCES

• Holcik M, Sonenberg N. 2005. Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 6:318–327. https://doi.org/10.1038/nrm1618.
   PubMed Web of Science ®Google Scholar
• Jia Y, Polunovsky V, Bitterman PB, Wagner CR. 2012. Cap-dependent translation initiation factor eIF4E: an emerging anticancer drug target. Med Res Rev 32:786–814. https://doi.org/10.1002/med.21260.
   PubMed Web of Science ®Google Scholar
• De Benedetti A, Graff JR. 2004. eIF-4E expression and its role in malignancies and metastases. Oncogene 23:3189–3199. https://doi.org/10.1038/sj.onc.1207545.
   PubMed Web of Science ®Google Scholar
• Graff JR, Konicek BW, Vincent TM, Lynch RL, Monteith D, Weir SN, Schwier P, Capen A, Goode RL, Dowless MS, Chen Y, Zhang H, Sissons S, Cox K, McNulty AM, Parsons SH, Wang T, Sams L, Geeganage S, Douglass LE, Neubauer BL, Dean NM, Blanchard K, Shou J, Stancato LF, Carter JH, Marcusson EG. 2007. Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. J Clin Invest 117:2638–2648. https://doi.org/10.1172/JCI32044.
   PubMed Web of Science ®Google Scholar
• Konicek BW, Stephens JR, McNulty AM, Robichaud N, Peery RB, Dumstorf CA, Dowless MS, Iversen PW, Parsons S, Ellis KE, McCann DJ, Pelletier J, Furic L, Yingling JM, Stancato LF, Sonenberg N, Graff JR. 2011. Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases. Cancer Res 71:1849–1857. https://doi.org/10.1158/0008-5472.CAN-10-3298.
   PubMed Web of Science ®Google Scholar
• Pelletier J, Graff J, Ruggero D, Sonenberg N. 2015. Targeting the eIF4F translation initiation complex: a critical nexus for cancer development. Cancer Res 75:250–263. https://doi.org/10.1158/0008-5472.CAN-14-2789.
   PubMed Web of Science ®Google Scholar
• Li Y, Yang D-Q. 2010. The ATM inhibitor KU-55933 suppresses cell proliferation and induces apoptosis by blocking Akt in cancer cells with overactivated Akt. Mol Cancer Ther 9:113–125. https://doi.org/10.1158/1535-7163.MCT-08-1189.
   PubMed Web of Science ®Google Scholar
• Avdulov S, Li S, Michalek V, Burrichter D, Peterson M, Perlman DM, Manivel JC, Sonenberg N, Yee D, Bitterman PB, Polunovsky VA. 2004. Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell 5:553–563. https://doi.org/10.1016/j.ccr.2004.05.024.
   PubMed Web of Science ®Google Scholar
• Chen L, Aktas BH, Wang Y, He X, Sahoo R, Zhang N, Denoyelle S, Kabha E, Yang H, Freedman RY, Supko JG, Chorev M, Wagner G, Halperin JA. 2012. Tumor suppression by small molecule inhibitors of translation initiation. Oncotarget 3:869–881. https://doi.org/10.18632/oncotarget.598.
   PubMed Web of Science ®Google Scholar
• Halaby MJ, Yang D-Q. 2007. p53 translational control: a new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics. Gene 395:1–7. https://doi.org/10.1016/j.gene.2007.01.029.
   PubMed Web of Science ®Google Scholar
• Yang DQ, Halaby MJ, Zhang Y. 2006. The identification of an internal ribosomal entry site in the 5′ untranslated region of p53 mRNA provides a novel mechanism for the regulation of its translation following DNA damage. Oncogene 25:4613–4619. https://doi.org/10.1038/sj.onc.1209483.
   PubMed Web of Science ®Google Scholar
• Kastenhuber ER, Lowe SW. 2017. Putting p53 in context. Cell 170:1062–1078. https://doi.org/10.1016/j.cell.2017.08.028.
   PubMed Web of Science ®Google Scholar
• Vousden KH, Prives C. 2009. Blinded by the light: the growing complexity of p53. Cell 137:413–431. https://doi.org/10.1016/j.cell.2009.04.037.
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Lane D, Levine AJ. 2000. Surfing the p53 network. Nature 408:307–310. https://doi.org/10.1038/35042675.
   PubMed Web of Science ®Google Scholar
• Mosner J, Mummenbrauer T, Bauer C, Sczakiel G, Grosse F, Deppert W. 1995. Negative feedback regulation of wild-type p53 biosynthesis. EMBO J 14:4442–4449.
   PubMed Web of Science ®Google Scholar
• Bellodi C, Kopmar N, Ruggero D. 2010. Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita. EMBO J 29:1865–1876. https://doi.org/10.1038/emboj.2010.83.
   PubMed Web of Science ®Google Scholar
• Kim DY, Kim W, Lee KH, Kim SH, Lee HR, Kim HJ, Jung Y, Choi JH, Kim KT. 2013. hnRNP Q regulates translation of p53 in normal and stress conditions. Cell Death Differ 20:226–234. https://doi.org/10.1038/cdd.2012.109.
   PubMed Web of Science ®Google Scholar
• Khan D, Katoch A, Das A, Sharathchandra A, Lal R, Roy P, Das S, Chattopadhyay S, Das S. 2015. Reversible induction of translational isoforms of p53 in glucose deprivation. Cell Death Differ 22:1203–1218. https://doi.org/10.1038/cdd.2014.220.
   PubMed Web of Science ®Google Scholar
• Halaby MJ, Li Y, Harris BR, Jiang S, Miskimins WK, Cleary MP, Yang DQ. 2015. Translational control protein 80 stimulates IRES-mediated translation of p53 mRNA in response to DNA damage. Biomed Res Int 2015:708158. https://doi.org/10.1155/2015/708158.
   PubMed Web of Science ®Google Scholar
• Halaby MJ, Harris B, Miskimins WK, Cleary MP, Yang D-Q. 2015. Deregulation of IRES-mediated p53 translation in cancer cells with defective p53 response to DNA damage. Mol Cell Biol 35:4006–4017. https://doi.org/10.1128/MCB.00365-15.
   PubMed Web of Science ®Google Scholar
• Gasco M, Shami S, Crook T. 2002. The p53 pathway in breast cancer. Breast Cancer Res 4:70–76. https://doi.org/10.1186/bcr426.
   PubMed Web of Science ®Google Scholar
• MacGrogan D, Bookstein R. 1997. Tumour suppressor genes in prostate cancer. Semin Cancer Biol 8:11–19. https://doi.org/10.1006/scbi.1997.0048.
   PubMed Web of Science ®Google Scholar
• Van Maerken T, Rihani A, Van Goethem A, De Paepe A, Speleman F, Vandesompele J. 2013. Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer. Cancer Lett 344:157–165. https://doi.org/10.1016/j.canlet.2013.11.002.
   PubMed Web of Science ®Google Scholar
• van Bokhoven A, Varella-Garcia M, Korch C, Johannes WU, Smith EE, Miller HL, Nordeen SK, Miller GJ, Lucia MS. 2003. Molecular characterization of human prostate carcinoma cell lines. Prostate 57:205–225. https://doi.org/10.1002/pros.10290.
   PubMed Web of Science ®Google Scholar
• Papadopoulos E, Jenni S, Kabha E, Takrouri KJ, Yi T, Salvi N, Luna RE, Gavathiotis E, Mahalingam P, Arthanari H, Rodriguez-Mias R, Yefidoff-Freedman R, Aktas BH, Chorev M, Halperin JA, Wagner G. 2014. Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an allosteric mechanism for dissociating eIF4G. Proc Natl Acad Sci U S A 111:E3187–E3195. https://doi.org/10.1073/pnas.1410250111.
   PubMed Web of Science ®Google Scholar
• Li S, Jia Y, Jacobson B, McCauley J, Kratzke R, Bitterman PB, Wagner CR. 2013. Treatment of breast and lung cancer cells with a N-7 benzyl guanosine monophosphate tryptamine phosphoramidate pronucleotide (4Ei-1) results in chemosensitization to gemcitabine and induced eIF4E proteasomal degradation. Mol Pharm 10:523–531. https://doi.org/10.1021/mp300699d.
   PubMedGoogle Scholar
• Moerke NJ, Aktas H, Chen H, Cantel S, Reibarkh MY, Fahmy A, Gross JD, Degterev A, Yuan J, Chorev M, Halperin JA, Wagner G. 2007. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G. Cell 128:257–267. https://doi.org/10.1016/j.cell.2006.11.046.
   PubMed Web of Science ®Google Scholar
• Ghosh B, Benyumov AO, Ghosh P, Jia Y, Avdulov S, Dahlberg PS, Peterson M, Smith K, Polunovsky VA, Bitterman PB, Wagner CR. 2009. Nontoxic chemical interdiction of the epithelial-to-mesenchymal transition by targeting cap-dependent translation. ACS Chem Biol 4:367–377. https://doi.org/10.1021/cb9000475.
   PubMed Web of Science ®Google Scholar
• Weber JD, Zambetti GP. 2003. Renewing the debate over the p53 apoptotic response. Cell Death Differ 10:409–412. https://doi.org/10.1038/sj.cdd.4401226.
   PubMed Web of Science ®Google Scholar
• Horn HF, Vousden KH. 2007. Coping with stress: multiple ways to activate p53. Oncogene 26:1306–1316. https://doi.org/10.1038/sj.onc.1210263.
   PubMed Web of Science ®Google Scholar
• Li Y, Xiong H, Yang D-Q. 2013. Functional switching of ATM: sensor of DNA damage in proliferating cells and mediator of Akt survival signal in post-mitotic human neuron-like cells. Chin J Cancer 31:364–372. https://doi.org/10.5732/cjc.012.10086.
   Google Scholar
• Ge J, Liu Y, Li Q, Guo X, Gu L, Ma ZG, Zhu YP. 2013. Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK. Biomed Environ Sci 26:902–911. https://doi.org/10.3967/bes2013.019.
   PubMed Web of Science ®Google Scholar
• Lin JN, Lin VC, Rau KM, Shieh PC, Kuo DH, Shieh JC, Chen WJ, Tsai SC, Way TD. 2010. Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation. J Agric Food Chem 58:1584–1592. https://doi.org/10.1021/jf9035782.
   PubMed Web of Science ®Google Scholar
• Lin HY, Tang HY, Davis FB, Davis PJ. 2011. Resveratrol and apoptosis. Ann N Y Acad Sci 1215:79–88. https://doi.org/10.1111/j.1749-6632.2010.05846.x.
   PubMed Web of Science ®Google Scholar
• Brown CJ, Lain S, Verma CS, Fersht AR, Lane DP. 2009. Awakening guardian angels: drugging the p53 pathway. Nat Rev Cancer 9:862–873. https://doi.org/10.1038/nrc2763.
   PubMed Web of Science ®Google Scholar
• Stegh AH. 2012. Targeting the p53 signaling pathway in cancer therapy: the promises, challenges and perils. Expert Opin Ther Targets 16:67–83. https://doi.org/10.1517/14728222.2011.643299.
   PubMed Web of Science ®Google Scholar
• Saiki AY, Caenepeel S, Cosgrove E, Su C, Boedigheimer M, Oliner JD. 2015. Identifying the determinants of response to MDM2 inhibition. Oncotarget 6:7701–7712. https://doi.org/10.18632/oncotarget.3116.
   PubMedGoogle Scholar
• Taylor AC, Shu L, Danks MK, Poquette CA, Shetty S, Thayer MJ, Houghton PJ, Harris LC. 2000. P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines. Med Pediatr Oncol 35:96–103. https://doi.org/10.1002/1096-911X(200008)35:2<96::AID-MPO2>3.0.CO;2-Z.
   PubMedGoogle Scholar
• Truitt ML, Conn CS, Shi Z, Pang X, Tokuyasu T, Coady AM, Seo Y, Barna M, Ruggero D. 2015. Differential requirements for eIF4E dose in normal development and cancer. Cell 162:59–71. https://doi.org/10.1016/j.cell.2015.05.049.
   PubMed Web of Science ®Google Scholar
• Bellodi C, Krasnykh O, Haynes N, Theodoropoulou M, Peng G, Montanaro L, Ruggero D. 2010. Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis. Cancer Res 70:6026–6035. https://doi.org/10.1158/0008-5472.CAN-09-4730.
   PubMed Web of Science ®Google Scholar
• Schmitt E, Paquet C, Beauchemin M, Bertrand R. 2007. DNA-damage response network at the crossroads of cell-cycle checkpoints, cellular senescence and apoptosis. J Zhejiang Univ Sci B 8:377–397. https://doi.org/10.1631/jzus.2007.B0377.
   PubMedGoogle Scholar
• Descamps G, Gomez-Bougie P, Tamburini J, Green A, Bouscary D, Maiga S, Moreau P, Le Gouill S, Pellat-Deceunynck C, Amiot M. 2012. The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction. Br J Cancer 106:1660–1667. https://doi.org/10.1038/bjc.2012.139.
   PubMed Web of Science ®Google Scholar
• Willimott S, Beck D, Ahearne MJ, Adams VC, Wagner SD. 2013. Cap-translation inhibitor, 4EGI-1, restores sensitivity to ABT-737 apoptosis through cap-dependent and -independent mechanisms in chronic lymphocytic leukemia. Clin Cancer Res 19:3212–3223. https://doi.org/10.1158/1078-0432.CCR-12-2185.
   PubMed Web of Science ®Google Scholar
• Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, Brennan J, MacLean KH, Han J, Chittenden T, Ihle JN, McKinnon PJ, Cleveland JL, Zambetti GP. 2003. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4:321–328. https://doi.org/10.1016/S1535-6108(03)00244-7.
   PubMed Web of Science ®Google Scholar
• Yu J, Zhang L. 2005. The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun 331:851–858. https://doi.org/10.1016/j.bbrc.2005.03.189.
   PubMed Web of Science ®Google Scholar
• Garrison SP, Phillips DC, Jeffers JR, Chipuk JE, Parsons MJ, Rehg JE, Opferman JT, Green DR, Zambetti GP. 2012. Genetically defining the mechanism of Puma- and Bim-induced apoptosis. Cell Death Differ 19:642–649. https://doi.org/10.1038/cdd.2011.136.
   PubMed Web of Science ®Google Scholar
• Hellen CU, Sarnow P. 2001. Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev 15:1593–1612. https://doi.org/10.1101/gad.891101.
   PubMed Web of Science ®Google Scholar
• Stoneley M, Willis AE. 2004. Cellular internal ribosome entry segments: structures, trans-acting factors and regulation of gene expression. Oncogene 23:3200–3207. https://doi.org/10.1038/sj.onc.1207551.
   PubMed Web of Science ®Google Scholar
• Ji B, Harris BR, Liu Y, Deng Y, Gradilone SA, Cleary MP, Liu J, Yang DQ. 2017. Targeting IRES-mediated p53 synthesis for cancer diagnosis and therapeutics. Int J Mol Sci 18:E93. https://doi.org/10.3390/ijms18010093.
   PubMed Web of Science ®Google Scholar
• Mazan-Mamczarz K, Galban S, Lopez de Silanes I, Martindale JL, Atasoy U, Keene JD, Gorospe M. 2003. RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation. Proc Natl Acad Sci U S A 100:8354–8359. https://doi.org/10.1073/pnas.1432104100.
   PubMed Web of Science ®Google Scholar
• Galban S, Martindale JL, Mazan-Mamczarz K, Lopez De Silanes I, Fan J, Wang W, Decker J, Gorospe M. 2003. Influence of the RNA-binding protein HuR in pVHL-regulated p53 expression in renal carcinoma cells. Mol Cell Biol 23:7083–7095. https://doi.org/10.1128/MCB.23.20.7083-7095.2003.
   PubMed Web of Science ®Google Scholar
• Schumacher B, Hanazawa M, Lee MH, Nayak S, Volkmann K, Hofmann R, Hengartner M, Schedl T, Gartner A. 2005. Translational repression of C. elegans p53 by GLD-1 regulates DNA damage-induced apoptosis. Cell 120:357–368. https://doi.org/10.1016/j.cell.2004.12.009.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay D, Houchen CW, Kennedy S, Dieckgraefe BK, Anant S. 2003. Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol Cell 11:113–126. https://doi.org/10.1016/S1097-2765(03)00012-1.
   PubMed Web of Science ®Google Scholar